Familial amyloidotic polyneuropathy: Protein aggregation in the peripheral nervous system

Journal of Molecular Neuroscience

Volumn 23, Issue 1-2, 2004, Pages 35-40

  Saraiva, Maria João ^a,b   Sousa, Mónica Mendes ^a,b   Cardoso, Isabel ^a   Fernandes, Rui ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

Familial amyloid polyneuropathy; Peripheral nerve; Peripheral neuropathy; Transthyretin

Indexed keywords

AMYLOID; PREALBUMIN;

CYTOTOXICITY; DISEASE ASSOCIATION; FAMILIAL AMYLOID POLYNEUROPATHY; FAMILIAL AMYLOIDOSIS; FIBER; NERVE DEGENERATION; NONHUMAN; PATHOLOGY; PATHOPHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN STRUCTURE; REVIEW; ANIMAL; BIOSYNTHESIS; DISEASE MODEL; GENETICS; HUMAN; METABOLISM; MOUSE; MUTATION; NEUROFILAMENT; PERIPHERAL NERVOUS SYSTEM; PROTEIN SECONDARY STRUCTURE; TRANSGENIC MOUSE;

ANIMALIA;

AMYLOID; AMYLOID NEUROPATHIES, FAMILIAL; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, TRANSGENIC; MUTATION; NEUROFIBRILS; PERIPHERAL NERVOUS SYSTEM; PREALBUMIN; PROTEIN STRUCTURE, SECONDARY;

EID: 4344714361     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Andrade C. (1952) A peculiar form of peripheral neuropathy. Familial atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 75, 408-427.
2. Araki S. (1984) Type I familial amyloidotic polyneuropathy (Japanese type). Brain Dev. 6, 128-133.
3. Araki S., Shigehiro Y., Murakami T., Watanabe S., Ikegawa S., Takahashi K., and Yamamura K. (1994) Systemic amyloidosis in transgenic mice carrying the human mutant transthyretin (met30) gene. Mol. Neurobiol. 8, 15-23.
4. Blake C. C. F., Geisow M. J., Swan I. D. A., Rerat C., and Rerat B. (1974) An X-ray study of the subunit structure of prealbumin. J. Mol. Biol. 61, 217-224.
5. Cardoso I., Goldsbury C. S., Müller S. A., Olivieri V., Wirtz S., Damas A. M., et al. (2002) Transthyretin fibrillogenesis entails the assembly of monomers: a molecular model for in vitro assembled transthyretin amyloid-like fibrils. J. Mol. Biol. 317, 687-699.
6. Combs C. K., Karlo J. C., Kao S. C., and Landreth G. E. (2001) β-Amyloid stimulation of microglia and monocytes results in TNF-α-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J. Neurosci. 21, 1179-1188.
7. Hofmann M. A., Drury S., Fu C., Qu W., Taguchi A., Lu Y., et al. (1999) RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97, 889-901.
8. Khono K., Palha J. A., Miyakawa K., Saraiva M. J., Ito S., Blaner W. S., et al. (1997) Analysis of amyloid deposition in a transgenic mouse model of homozygous familial amyloidotic polyneuropathy. Am. J. Pathol. 150, 1497-1508.
9. Munar-Qués M., Costa P. P., Saraiva M. J. M., Farré C. V., Bernat C. M., Luna C. C., and Alberti J. F. F. (1997) Familial amyloidotic polyneuropathy. TTR Met 30 in Majorca (Spain). Amyloid 4, 181-186.
10. Radi R., Peluffo G., Alvarez M. N., Naviliat M., and Cayota A. (2001) Unraveling peroxynitrite formation in biological systems. Free Radic. Biol. Med. 30, 463-488.
11. Saraiva M. J. M. (2001) Transthyretin mutations in hyperthyroxinemia and amyloid diseases. Hum. Mutat. 17, 493-503.
12. Saraiva M. J. M., Birken S., Costa P. P., and Goodman D. S. (1984) Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type. Definition of molecular abnormality in transthyretin (prealbumin). J. Clin. Invest. 74, 104-119.
13. Sebastião M. P., Saraiva M. J., and Damas A. M. (1998) The crystal structure of amyloidogenic Leu55 → Pro transthyretin variant reveals a possible pathway for transthyretin polymerization into amyloid fibrils. J. Biol. Chem. 273, 24715-24722.
14. Soprano D. R., Herbert J., Soprano K. J., Schon E. A., and Goodman D. S. (1985) Demonstration of transthyretin mRNA in the brain and other extrahepatic tissues in the rat. J. Biol. Chem. 260, 11793-11798.
15. Sousa M. M., Cardoso I., Fernandes R., Guimaraes A., and Saraiva M. J. (2001) Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates. Am. J. Pathol. 159, 1993-2000.
16. Sousa M. M., Du Yan S., Fernandes R., Guimaraes A., Stern D., and Saraiva M. J. (2001) Familial amyloid polyneuropathy: receptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways. J. Neurosci. 21, 7576-7586.
17. Sousa M. M., Fernandes, R., Palha J. A., Taboada A., Vieira P., and Saraiva M. J. (2002) Evidence for early cytotoxic aggregates in transgenic mice for human transthyretin Leu55Pro. Am. J. Pathol. 161, 1935-1948.
18. Yan S. D., Chen X., Fu J., Chen M., Zhu H., Roher A., et al. (1996) RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 382, 685-691.
19. Yan S. D., Roher A., Schmidt A. M., and Stern D. M. (1999) Cellular cofactors for amyloid beta-peptide-induced cell stress. Moving from cell culture to in vivo. Am. J. Pathol. 155, 1403-1411.
20. Yi S., Takahashi K., Naito M., Tashiro F., Wakasugi S., Maeda S., et al. (1991) Systemic amyloidosis in transgenic mice carrying the human mutant transthyretin (Met30) gene. Pathologic similarity to human familial amyloidotic polyneuropathy, type I. Am. J. Pathol. 138, 403-412.